EU and US could reach trade deal this weekend - Reuters
On Wednesday, Wells Fargo (NYSE:WFC) analysts downgraded Ecolab Inc . (NYSE:ECL) shares from Overweight to Equal Weight and reduced the price target to $240 from $265. The revision follows concerns about slowing industrial activities due to tariffs and softening market conditions. According to InvestingPro data, six analysts have recently revised their earnings estimates downward, while the stock currently trades at a P/E ratio of 32.25x. Analysts at the firm pointed to contracting industrial production and Purchasing Managers’ Index (PMI) as indicators of Ecolab’s weakening end markets. Based on InvestingPro’s Fair Value analysis, the stock appears to be trading above its intrinsic value.
The high-tech sector, while experiencing thematic tailwinds, was noted as not yet significantly impacting Ecolab’s revenue, contributing only about 2%. Food production volumes have shown limited activity in the first quarter, although beverage production has remained robust. The paper industry is facing challenges with rising natural gas prices increasing input costs. Ecolab’s Institutional & Specialty segment is expected to decelerate further, with companies like McDonald’s (NYSE:MCD) reporting a slowdown and restaurant traffic declining sharply throughout the first quarter.
Ecolab’s healthcare segment, which generates approximately $0.7 billion in sales, is anticipated to have a 100 basis point negative impact on margins as it will be included in the Institutional & Specialty results starting in the first quarter. Despite exiting low-margin businesses and implementing pricing strategies, healthcare is expected to stabilize. During a conference in mid-March, Ecolab indicated that first-quarter organic compound growth was tracking closer to 3% compared to the greater than 4% target for 2025, although earnings per share (EPS) are projected to be maintained through cost-cutting measures and less severe foreign exchange headwinds.
Analysts expressed concern over potential impacts on Ecolab’s customers in the Life Sciences sector, which makes up 4% of sales, due to announced research funding cuts by the National Institutes of Health (NIH). This contrasted with the solid demand in pest control, accounting for 7% of sales, despite year-over-year colder temperatures. Wells Fargo analysts showed a preference for Rollins Inc . (NYSE:ROL), a pure-play pest control company, maintaining an Overweight rating for it.
The downgrade to Equal Weight for Ecolab reflects expectations of a downward revision in organic compound growth guidance to 3% due to deteriorating end markets and tariff uncertainties. Despite these challenges, InvestingPro reveals the company’s impressive track record of maintaining dividend payments for 55 consecutive years, with a current dividend yield of 1.09%. For investors seeking deeper insights, InvestingPro offers 8 additional ProTips and comprehensive analysis in its Pro Research Report, available for over 1,400 US stocks. Despite Ecolab’s ability to implement price increases, analysts at Wells Fargo believe that cost reductions and foreign exchange benefits may not suffice to support the stock price. The firm has adjusted its 2025 and 2026 organic compound growth estimates to 2.7% and 3.4%, respectively, down from 4.8% and 4.9%, and has lowered EPS forecasts to $7.50 and $8.27 from $7.55 and $8.47. The new price target of $240 is based on 29 times the projected 2026 EPS, reduced from the previous multiple of 31.
In other recent news, Ecolab Inc. reported a significant financial development by securing a new $2 billion unsecured revolving credit facility. This agreement, led by Bank of America, extends the maturity date to March 2030 and replaces the previous facility set to mature in April 2026. The credit line will support Ecolab’s corporate activities, including potential acquisitions and debt repayment. Additionally, BMO Capital Markets and Piper Sandler have raised their price targets for Ecolab, with BMO adjusting its target to $305 and Piper Sandler increasing it to $310. Both firms maintain positive ratings, citing Ecolab’s strong earnings potential and strategic initiatives.
Furthermore, Ecolab has announced a regular quarterly cash dividend of $0.65 per share, highlighting its commitment to shareholders. The company also appointed Michel Doukeris, CEO of AB InBev, to its board, bringing valuable global executive experience. These developments reflect Ecolab’s ongoing efforts to strengthen its financial position and enhance its board’s expertise.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.